3 terminated. 3 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
| Phase 3 | 3 | Terminated 3 |
Follow Hypopigmentation: new trials by email Literature Review of Hypopigmentation trials Research Report on Hypopigmentation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assess the Efficacy and Safety of SHR0302 Ointment in Adult Patients With Vitiligo Low Dose SHR0302 Ointment BID, High Dose SHR0302 Ointment BID, Placebo Comparator: Vehicle - Vitiligo | Phase 2 / Phase 3 | Terminated | Reistone Biopharma Company Limited | 75 | 2020-01-29 | 2022-07-13 |
| Assessing the Efficacy of Needling With or Without Corticosteroids in the Repigmentation of Vitiligo Needling, Triamcinolone - Vitiligo | Phase 2 / Phase 3 | Terminated | Rutgers, The State University of New Jersey | 22 | 2014-09-01 | 2017-07-25 |
| Maintenance Treatment of Non Segmental Vitiligo With Tacrolimus Ointment 0.1% Versus Control Protopic, Placebo : Diprobase - Pigmentation Disorders, Vitiligo | Phase 2 / Phase 3 | Terminated | Centre Hospitalier Universitaire de Nice | 35 | 2011-12-01 | 2014-09-05 |
Vitiligo (3) · Pigmentation Disorders (1)
Skin Diseases (3) · Skin and Connective Tissue Diseases (3) · Pigmentation Disorders (2) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Tacrolimus (1) · Triamcinolone (1) · Triamcinolone Acetonide (1)
Centre Hospitalier Universitaire de Nice (1) · Reistone Biopharma Company Limited (1) · Rutgers, The State University of New Jersey (1)
China (1) · France (1) · United States (1)
Babar Rao, MD (1)